Postinduction Carbamazepine Clearance in an Adult Psychiatric Population
- 8 July 1991
- journal article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 11 (4), 296-302
- https://doi.org/10.1002/j.1875-9114.1991.tb04291.x
Abstract
The objective of this study was to describe the postinduction clearance of carbamazepine (CBZ) in adult psychiatric patients by population pharmacokinetic analysis using the NONMEM program. Specifically, an estimate of CBZ clearance and insight into the effect of common patient characteristics on clearance were sought. Steady-state trough CBZ serum concentrations, CBZ dosing history, concomitant drug administration, and other data from 45 patients were collected retrospectively. A one-compartment model with first-order absorption and first-order elimination was used, with absorption rate, bioavailability, and volume of distribution fixed to literature values. No evidence was found that race, sex, age, ethanol use, smoking, and concomitant lithium significantly affected CBZ clearance. In the final model, clearance was based on lean body weight. The coefficient of variation for clearance estimates was 16.5%. Residual variability was modest. Estimates for volume of distribution, rates of absorption and elimination, and bioavailability could not be pursued rigorously. Although these results may assist in understanding CBZ disposition in this population, their general clinical application should be approached with caution.This publication has 15 references indexed in Scilit:
- Carbamazepine Auto- and Hetero-Induction Complicating Clinical CareJournal of Clinical Psychopharmacology, 1989
- Carbamazepine Clearance in Paediatric Epilepsy PatientsClinical Pharmacokinetics, 1989
- The population pharmacokinetics of theophylline in neonates and young infantsJournal of Pharmacokinetics and Biopharmaceutics, 1989
- Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-EpoxideClinical Pharmacokinetics, 1986
- Carbamazepine Metabolism in ManClinical Pharmacokinetics, 1985
- Profile of clinical efficacy and side effects of carbamazepine in psychiatric illnessActa Psychiatrica Scandinavica, 1984
- Carbamazepine and Behavior Therapy for Aggressive BehaviorBehavior Modification, 1983
- Should clearance be normalised to body surface or to lean body mass?British Journal of Clinical Pharmacology, 1981
- Dose-Dependency of the Ratio Between Carbamazepine Serum Level and Dosage in Patients with EpilepsyTherapeutic Drug Monitoring, 1981
- Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1980